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Pterygium is a common worldwide external eye disease, 
affecting populations especially in tropical and sub-tropicalarea [1-5]. It 
is a degenerative, triangular, wing-shaped, fibro vascular Although 
pathogenesis is still a riddle, but can be attributed to u-v radiation, 
dryness, exposure to wind, dustand heat [1-5]. Newer theories suggests 
of damage of limbal stem cells and activation of matrix 
metalloproteinase [5]. 
        The presence of unwanted growth on eye, decreased visual 
acuity due to astigmatism and pterygium covering pupil, headache, and 
restriction of ocular movements, constant irritation and dryness are the 
chief complaints of the patients. To get rid of the above complaints 
temporary and permanent methods have evolved. 
Temporary relief can be obtained by decongestants and 
lubricating topical medications, While surgery is the permanent 
solution of it. Till date no surgical method is safe in terms of achieving 
zero recurrence rate. 
Various pterygium surgeries in order of increasing 
complexity are:  
1) Bare sclera excision [6] ,  
2) Excision with conjunctival closure,  
3) Excision with antimitotic adjunctive therapy and  
4) Ocular surface transplantation technique.  
The aim is to excise pterygium and prevent its recurrence. 
       Among various methods, conjunctival autografting is a 
promising technique for pterygium surgery and has gained popularity 
in last 2-3 decades because of its easy accessibility, low recurrence rate 
and less complication [7-11]. Kenyon and colleague [7] proposed the 
use of free conjunctival autograft for preventing recurrence after 
pterygium surgery which was supported by several other studies [8-11]. 
In these studies graft was secured by sutures. Later on, use of fibrin glue 
[12-14] resulted in the decrease of suture related complications, intra-
operative time and post operative discomfort. Potential risks of prion 
and viral transmission and anaphylaxis with fibrinogen led eventually 
to description of sutureless and gluefree conjunctival autograft [15] 
technique wherein the autologus fibrin facilitates the adherence of the 
graft to the bed.   Therefore the purpose of this study was to assess the 
outcome of sutureless and gluefree conjunctival autograft technique for 
primary pteerygium. 
 
1.1 Aims and Objectives 
The aims and objectives of present study are: 
1. To assess the clinical success in terms of recurrence rate 
2. Safety profile of the procedure 
 
2. Materials and Method 
This was a prospective, non comparative, interventional case 
series enrolling 52 eyes of 50 patients with primary pterygium between    
June 2011-May 2012 attending the outdoor of our eye hospital, a 
tertiary care center affiliated with S.P. Medical College, Bikaner after 
obtaining permission from institutional review board. The patients 
were informed about the design of the study and procedure, and 
written consent was obtained from all patients. Patients with recurrent 
pterygium, history of ocular trauma, blephritis, keratits, dry eye, 
entropion, ectropion, other ocular surface pathologic features and 
major systemic illness like D.M, collagen vascular disease were excluded 
from the study. All the eyes underwent detailed ocular examination like 
visual-acuity, automated refraction, tonometry and slit lamp 
biomicroscopy. Characteristics of the pterygium (location, grade, size) 
were noted and graded according to the extent of cornea covered by 
pterygium head. (Table-1) 
Table 1: Grading of pterygium 
GRADE I Pterygium invading <1.5 mm of cornea 
GRADE II Pterygium invading  > 1.5 mm of cornea 
GRADE III Pterygium invading over half the radius of cornea 
GRADE IV Pterygium reaching almost upto the centre of cornea 
 
2.1 Surgical Technique 
All of the patients underwent pterygium excision followed by 
superior conjunctival autografting surgery performed under local 
anesthesia by peribulbar block. The neck of pterygium was grasped 
with toothed forceps. The head of the pterygium was then, excised off 
the cornea using no-15 bard parker blade. The keratectomy was 
continued up to the limbus, thus freeing the pterygium off the cornea, 
with the help of spring scissor, the pterygium was excised 
approximately midway between the limbus and canthus. Sub 
conjunctival fibrous tissue under the pterygium was excised and the 
edges were undermined about 1mm. Cautery was not applied to the 
bleeding vessels. 
      The bare area of the sclera was measured using castor-Viejo 
calipers and graft of the same size was procured from supero-temporal 
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bulbar conjunctiva after marking with the help of trypan blue and 
separating it properly from underlying tenon’s capsule with the help of 
sub conjunctival injection of saline. Graft was taken after blunt 
dissection of conjunctiva from the tenon’s capsule and was then slided 
over the cornea without lifting the tissue off the cornea, towards the 
bare sclera and it was spread and positioned such that the limbal 
polarity was maintained. Care was taken to obtain a thin graft without 
any button hole and close to the limbus. The edges of the graft were 
placed below the undermined edges of the surrounding conjunctiva 
(Figure 1). 
 
Figure 1: Surgical Procedure 
 
      Pad and bandage applied for 1 day and patients were put on 
oral analgesic –anti-inflammatory (Diclofenac+Paracetamol) tablets 
twice a day for 3 days. 
 
2.2 Post operative follow up 
After surgery, biomicroscopic examination was performed on 
the first day, and topical antibiotic (Gatifloxacin 0.3%) and steroid 
(Prednisolone acetate 1%)  drops  four times a day was prescribed 
which was tapered in subsequent weeks and artificial tears(Carboxy 
methyl cellulose 0.5%) was given four times a day. Patients were 
examined weekly for a month then monthly for 6 months and at 3 
month intervals for a year. Snellen visual acuity and slit lamp 
microscopic examination were performed at each follow up. 
Photographic records of all patients were taken (Figure 2).Patients 
post-operative complaints were also considered in our study. 
 
Figure 2: Pre-operative and post-operative photo graph 
3. Results 
All patients completed the 12 month follow up without any 
drop outs from the study. Demographic  data of patients are displayed 
in (TABLE-2).There were 29 males and 21 females in the study with 
mean age 40.9 year(12.09) and range 21 -60 years. 
Table 2: Demographic details 
Number of eyes (patients) 52(50) 
Age in years 
Mean (SD) 40.9(12.09) 
Range 20-60 years 
Sex 












SD – Standard Deviation *nasal was operated 
The patient had pterygium of grade I - 12, grade II -12, grade  
III- 17, grade  IV- 11 and 48 nasal, 1 temporal, 2  nasal bilateral and 1 
double (nasal one operated). 
The indications of pterygium surgery are displayed in (Table-
3). Most common indication was foreign body sensation and watering 
followed by diminution of vision and cosmetic disfigurement. 
Table -3: Pre operative complaints 
  NUMBER OF PATIENTS 
Foreign body sensation and watering 34 
Diminution of vision 17 
Cosmetic disfigurement  5 
No significant intraoperative complications were noted. 
Subjective complaints of patient were also noted at each follow up as 
shown in (Table 4). No subjective complaints were experienced after 1 
month. 
Table 4: Post operative subjective complaints 
Complaints  Number of patients 
 Day  1 Week  1 Week 2 Month 1 
Redness 46 41 27 9 
Discomfort  38 14 1 0 
Pain  21 0 0 0 
Post-operative complications  (Table 5) like graft 
displacement notice in 4 cases (7.69%) on 1stpost-operative day which 
was repositioned with the help of 30 gauze ½ inch needle under topical 
anesthesia with the help of slit lamp and was found to remain in place 
on subsequent follow up. Mild graft edema was noted in 4 (7.69%) 
cases in first week which resolved without any intervention in 
subsequent follow up. 
There was hematoma below graft in 3 (5.76%) cases and in 1 
case it persisted for 1 month and we started oral prednisolone 60 mg 
tablet o.d which was tapered in subsequent follow up and it responded 
well. Retention cysts, granuloma or corneal dellen were not seen in our 
study. The donor site was re epithelized in 7-10 days. 
Table 5: Complications 
Clinical signs 









Sub conjunctival haemorrhage 48 46 28 11 
Serous exudates 4 2 1 0 
Haematoma * 3 1 1 1 
Graft displacement** 4 0 0 0 
Retention cyst 0 0 0 0 
Granuloma formation 0 0 0 0 
Corneal dellen 0 0 0 0 
*noted on 1st post op day – repositiond successfully –taken up well 
subsequently 
**in one case oral steroid was started and responded well 
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Improvement in visual acuity was observed in 32 (64%) 
cases. The absolute value of astigmatism was found to decrease from an 
average 1.47+1.53 D to 0.89+0.92 D (p<0.01) at the 1 month follow up 
(Table 6). 








1.47 +1.53 D 0.89+0.92 D* 
*P < 0.01 paired t test 
Recurrence was seen in 1 (1.92%) case that had temporal 
pterygium. It was observed at 6th month follow up. Recurrence was 
defined as regrowth of fibro vascular tissue which crosses the limbus 
onto the cornea. 
 
4. Discussion 
Current surgical methods to prevent pterygium recurrence 
include conjunctival autograft, limbal and limbal–conjunctival 
transplant, conjunctival flap and conjunctival rotation autograft surgery, 
amniotic membrane transplant, cultivated conjunctival transplant, 
lamellar keratoplasty, and the use of fibrin glue. All of these techniques 
involve the use of sutures or fibrin glue and are therefore vulnerable to 
associated complications. The adjuvant use of mitomycin C and 
radiotherapy have been described. Radiotherapy and chemotherapy 
reduces the recurrence rate, yet serious complications are associated 
with their use.[17-20] The presence of sutures may lead to prolonged 
wound healing and fibrosis.[21] Subsequent complications such as 
pyogenic granuloma formation are easily treated; others such as 
symblepharon formation, forniceal contracture, ocular motility 
restriction, diplopia, scleral necrosis, and infection are much more 
difficult to manage and may be sight threatening. To overcome suture 
related problems and to reduce the intraoperative time, fibrin glue was 
introduced and its efficacy for the conjunctival grafting has been 
established.[12-14] Fibrin glues are currently manufactured from 
human plasma and therefore carry the theoretical risk of anaphylaxis 
and transmission of prions and viruses.[15] New devices, such as cryo 
seal FS system, that generates fibrin sealant from autologous blood may 
eliminate the current risks associated with pooled plasma, but, they are 
not currently in wide spread use. 
 To encounter problems related with sutures and fibrin glue 
new method of sutureless and gluefree conjunctival autograft in 
pterygium surgery came into practice which have less subjective 
complaints like that post-operative pain and prolonged redness .In this 
procedure graft was adhered to the bare sclera by the natural 
coagulation cascade system and cauterization of sclera bed was avoided 
hence the graft was as stable as those secured with suture and fibrin 
glue. 
 To preserve the superior conjunctiva, amniotic membrane 
can be used to cover the sclera after pterygium surgery for reducing the 
recurrence.[8,22] But it possesses the risk of contamination which 
cannot be overlooked. 
 We treated 52 eyes of 50 patients with primary pterygium 
with supero-temporal conjunctival autografting without the use of 
sutures or glue. In our case series the recurrence rate was 1.92% .These 
rates are comparable to the other studies and better than some reports 
like Ratanlingam V[23] and co workers who had reported recurrence of 
4.4% in conjunctival autografting with suture group and 15.9% in fibrin 
glue group, and, Tananuvat N and Martin T [24] who had reported 
recurrence rate of 40.9% with amniotic membrane transplantation 
.Similar case series was done by Johnny Moore et al reported no 
recurrence after 9 months follow up. 
 Post-operative subjective complaints like discomfort and 
mild pain was observed on 1 postoperative day which almost resolved 
within a week. Sub conjunctival hemorrhage was present in almost all 
case (92.30%) on 1 post-operative day which resolved within a month. 
Srinivasan S et al[25] had compared the degree of sub conjunctival 
hemorrhage, conjunctival inflammation and graft stability followed by 
the use of sutures and fibrin glue reported that when using fibrin glue, 
degree of inflammation was significantly less than with sutures at 1 
month and 3 months post operatively. Conjunctival graft secured with 
fibrin glue was as stable as those secured with sutures. 
Hematoma was seen in 3 cases (5.76%) on day 1 which 
resolved within a week in 2 cases, it could be attributed to fragility of 
newly formed blood vessels. In 1 patient it lasted long up to 1 month for 
which oral prednisolone tablet 60 mg 1 o.d dose for 7 days followed by 
40 mg 1 o.d dose for next 7 days with tablet ranitidine 1o.d was started 
and it resolved completely. Graft displacementwas found in 4 (7.69%) 
cases each. 
 This displacement was reflected back under local anesthesia 
(xylocaine 4%), using a 30 G ½ inch needle under slit – lamp 
visualization. The condition did not recur. 
 No complaints were observed at month 2 and 3and later on. 
Complications like tenon’s  granuloma and conjunctival cyst formation, 
graft necrosis and pyogenic granuloma and giant papillary 
conjunctivitis reported previously in sutured conjunctival autograft 
were not seen in the present study . 
 Improvement in visual acuity was observed in 32 patients 
representing, decrease in astigmatism [26] ranging from 0.50d 
cylinder–4.50d cylinder in almost all cases except those who had 
cataract. 
 On the basis of this study, it was concluded that other 
surgical methods are associated with complications. Sutures are related 
with foreign body related complications while fibrin glue is linked with 
risk of transmissible disease.  Fibrinogen compounds may also be 
susceptible to inactivation by iodine preparation such as those used for 
conjunctival disinfection before pterygium surgery. The apposition of 
the lids to the bulbar conjunctiva provides a natural biological dressing 
and confers a unique wound – healing environment. The complications 
encountered in the present study were of trivial nature. No serious 
ocular side effects were observed in this study. Improvement in visual – 
acuity and decrease in astigmatism was also observed in our study. In 
the view of low recurrence rate with minimum and mild complications, 
pterygium excision with conjunctival autograft by sutureless and 




This study opens a new door towards the better surgical 
management  of  pterygium with less post-operative complication and 
lesser recurrence rate . The results of the technique used in the present  
study encourage us to use it more frequently in future as it compares 
favourably with other technique and is very cost effective as well when 
compared to glue and amniotic membrane graft. 
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